Genotyping of single nucleotide polymorphisms (SNPs) in large populations presents a great challenge, especially if the SNPs are embedded in GCrich regions, such as the codon 112 SNP in the human apolipoprotein E (apoE ). In the present study, we have used immobilized locked nucleic acid (LNA) capture probes combined with LNAenhancer oligonucleotides to obtain ef®cient and speci®c interrogation of SNPs in the apoE codons 112 and 158, respectively. The results demonstrate the usefulness of LNA oligonucleotide capture probes combined with LNA enhancers in mismatch discrimination. The assay was applied to a panel of patient samples with simultaneous genotyping of the patients by DNA sequencing. The apoE genotyping assays for the codons 112 and 158 SNPs resulted in unambiguous results for all patient samples, concurring with those obtained by DNA sequencing.
INTRODUCTION
Recently, there has been considerable interest in developing a method for genotyping of the apolipoprotein E (apoE) in diagnostic screening. Single base alterations within codons 112 and 158 of the apoE gene account for three common alleles (e2, e3 and e4), and the resulting six genotypes of the ApoE protein arise from the expression of any two of the three alleles (1) . The apoE genotypes play a key role in the diagnosis of type III hyperlipidemia (2) and have also shown to be an important risk factor in the development of Alzheimer's and cardiovascular diseases (3, 4) .
The apoE codon 112 single nucleotide polymorphism (SNP) is located in a highly GC-rich region (2) . Genotyping of SNPs embedded in GC-rich regions is often dif®cult because of the small difference between the melting temperatures of the perfectly matched and the mismatched targets. Furthermore, polymorphic GC-rich repetitive sequences may be non-accessible to hybridization with complementary oligonucleotide capture probes due to their involvement in secondary structure formation via intermolecular Watson± Crick base-pairing (5) . Finally, SNP detection in doublestranded PCR amplicons can be complicated by the presence of a complementary strand, which can act as a competitor to the SNP detection probe (6) .
The common ApoE polymorphisms have previously been determined by isoelectric focusing of the proteins (7, 8) , and more recently by Southern or dot blots hybridized with allelespeci®c oligonucleotide probes or by restriction fragment length polymorphism (9±11). Utilizing the PCR technique for the apoE genotyping has also allowed other methods to be developed. Among these are ampli®cation refractory mutation system (12), real-time PCR (6), oligonucleotide ligation assay (13) , primer extension (14) , heteroduplex analysis (15), denaturing gradient gel electrophoresis (16) and single-strand conformational polymorphism (17) . A common feature for the aforementioned methods is that they are generally expensive, time-consuming and dif®cult to automate due to the requirement of enzymatic digestion and gel electrophoresis. Thus, high-throughput screening of the apoE polymorphisms in human populations calls for robust, reliable and cost-effective methods with optimized performance in genotyping applications. Here, we describe a novel method for apoE genotyping based on the hybridization of PCR amplicons to allele-speci®c locked nucleic acid (LNA) capture probes in the presence of a LNA-enhancer oligonucleotide, followed by detection of the hybrids using an ELISA-like technique (18, 19) . The LNA capture probes are attached to microtiter wells by photochemical immobilization using an anthraquinone (AQ) moiety in the LNA capture oligonucleotides (20) . The genomic DNA for a selected test panel of patient samples was characterized using both the apoE microtiter plate assay and DNA sequencing. The genotypes obtained with the LNA capture method were in full agreement with those obtained by sequencing of the DNA samples.
MATERIALS AND METHODS

Immobilization of LNA capture probes
The capture probes (Table 1) were photo-immobilized to the microtiter wells using an AQ moiety as described by Koch et al. (20) . After coupling, the plates were treated according to érum et al. (18) . 
Determination of the melting temperatures
Determination of the melting curves was performed without the AQ and the DNA linker moieties. The melting temperatures of the LNA/DNA and the corresponding DNA/DNA duplexes were determined as described by Wahlestedt et al. (21) using 1.0 mM concentrations of the two complementary oligonucleotides in a T m buffer (10 mmol/l sodium phosphate buffer pH 7.0, 100 mmol/l NaCl, 0.1 mmol/l EDTA). The salt concentration in the T m buffer corresponds to that of the hybridization buffer in the apoE microtiter plate assay.
In vitro ampli®cation of the apoE PCR products Two PCR amplicons encompassing either the apoE codon 112 or 158 were generated from genomic DNA (extracted from 5 ml of EDTA-anticoagulated blood using a Roche DNA Isolation reagent set according to the manufacturer's instructions) either with the codon 112 forward primer, 5¢-biotin-GGCGCGGACATGGAGGAC-3¢, and the codon 112 reverse primer, 5¢-TGCACCTCGCCGCGGTAC-3¢, resulting in a 58 bp amplicon, or the codon 158 forward primer, 5¢-biotin-CGGCTCCTCCGCGATGCC-3¢, and the codon 158 reverse primer, 5¢-CCCGGCCTGGTACACTGC-3¢, resulting in a 57 bp amplicon. PCRs (50 ml) were prepared by mixing 15 mmol/l Tris±HCl pH 8.0, 50 mmol/l KCl (GeneAmp Gold buffer, PE Biosystems), 2.5 mmol/l MgCl 2 , 200 mmol/l of each dATP, dCTP, dGTP and dTTP (Amersham Pharmacia Biotech), 1 mmol/l forward primer, 1 mmol/l reverse primer; 1.25 U (0.25 ml of a 5 U/ml) AmpliTaq Gold polymerase (PE Biosystems) and 100 ng of genomic DNA as template. After an initial 15 min denaturation step at 95°C, 30 cycles of PCR were carried out (40 s at 95°C, 40 s at 65°C and 40 s at 72°C), followed by extension at 72°C for 10 min. Puri®cation of the PCR amplicons was not necessary.
Genotyping of the apoE SNPs from clinical samples
The microtiter plate assay was performed by mixing 20 ml of the PCR amplicon or 0.1 mmol/l synthetic 50mers DNA oligonucleotides encompassing either the codon 112 SNP or the codon 158 SNP with 20 ml of denaturation buffer (125 mmol/l NaOH, 8 mmol/l EDTA, 0.2 g/l phenol red) followed by incubation for 5 min at room temperature. After the addition of 200 ml of hybridization buffer (50 mmol/l sodium phosphate buffer pH 7.0, 0.1 ml/100 ml Tween-20) and the different LNA/DNA-enhancer oligonucleotides for the codon 112, the hybridization mixture was transferred to the coated wells (100 ml/well) containing capture probes for the apoE codon 112 or 158 SNPs and hybridized for 30 min at 37°C. The wells were subsequently washed three times in washing buffer [300 ml/well; 0.5Q SSC buffer (75 mmol/l NaCl, 7.5 mmol/l sodium citrate, pH 7.0), 0.1 ml/100 ml Tween-20] followed by the addition of 100 ml of conjugate solution [1 mg/l horseradish peroxidase-streptavidin (Pierce) diluted in the washing buffer] per well and incubation for 15 min at 37°C. Finally, the wells were washed six times with washing buffer (300 ml/well) and 100 ml of a chromogenic substrate was added per well [3,3¢,5,5¢±tetramethylbenzidine (TMB one) or orthophenylenediamine (OPD); both from KemEnTec]. The microtiter plate was then incubated in the dark for 10±15 min at room temperature followed by the addition of 100 ml/well of 0.5 mol/l H 2 SO 4 to stop the reaction. The absorbance was read at l = 450 nm (TMB one) or at l = 492 nm (OPD) using an Elisa reader (Wallac Victor 2 for the TMB one substrate and SLT spectra Elisa reader for the OPD substrate).
RESULTS
We have previously described the use of LNA capture probes in SNP genotyping assays for Leiden factor V (18) and Table 1 . Optimization of capture probes and thermostability of the LNA capture probe sequences against the complementary DNA targets apolipoprotein B (19) . In our ®rst attempt to develop an apoE genotyping assay for the common single base alterations within the codons 112 (TGC®CGC) and 158 (CGC®TGC) (2), we designed the LNA capture probes as shown in Table 1 . The capture probes contained an AQ moiety at the 5¢ end, which made it possible to covalently link the capture probes to the polymer surface of microtiter wells by soft UV-light illumination (20) . For optimal hybridization, a 15mer DNA linker separated the AQ moiety from the sequence-speci®c capture part (18) . The capture part consisted of eight LNA nucleotides and one DNA nucleotide complementary to the sense strand of the apoE codon 112 or 158 SNPs.
The speci®city of the LNA genotyping assay was ®rst assessed with synthetic single-stranded DNA (ssDNA) targets, thus mimicking the sense strand encompassing either the codon 112 or 158 SNPs. The double-stranded DNA (dsDNA) targets were generated using PCR ampli®cation. The results for both ssDNA as well as dsDNA targets are presented in Table 1 as the signal from the perfectly matched target (S) relative to the background signal (N) obtained with the single nucleotide mismatched target. The apoE codon 158 capture probes (entries 1 and 2) were able to hybridize speci®cally to ssDNA and dsDNA targets, respectively. In both cases the hybridization signal from the perfectly matched targets was more than 10 times higher than that from the single nucleotide mismatched targets. The difference in duplex melting temperatures between perfectly matched and mismatched ssDNA targets for the codon 158 capture probes also inferred that optimal conditions for speci®c hybridization-based genotyping could be identi®ed ( Table 1) .
The apoE codon 112 SNP is embedded in a CG-rich region as opposed to the codon 158 SNP. Application of the LNA genotyping assay to the codon 112 SNP resulted in low signalto-noise (S/N) ratios for the dsDNA targets, although reasonable values were obtained for the ssDNA targets. The S/N ratio for the capture probes genotyping the apoE codon 112 CGC (entry 3) and codon 112 TGC (entry 4) using ssDNA targets were 12.9 and 33.6, respectively. To prevent unspeci®c hybridization, the DNA linker moiety in the LNA capture probes was changed to a 15mer non-base linker. However, when the dsDNA targets were applied to the capture probes both the hybridization signals and the S/N ratios were still unsatisfactorily low. Further oligonucleotide designs for the codon 112 CGC capture probe (entries 5 and 6) were tested in hybridizations to optimize the S/N ratio, but none of these performed better than the capture probe entry 3 (Table 1) . Although the difference in duplex melting temperatures between perfectly matched and mismatched ssDNA targets for the codon 112 capture probes exceeds 15°C (Table 1) , mismatch discrimination could be seriously hampered by competition from the complementary non-target strand (6) . Here, we show that introduction of LNA-enhancer oligonucleotides in combination with the codon 112 capture probes dramatically increased the speci®c capture ef®ciency.
To improve hybridization between the capture probe and target it has previously been shown that DNA oligonucleotides can be used as enhancers to promote speci®c hybridization (22, 23) . Thus, we designed a set of LNA-enhancer oligonucleotides, respectively, in the proximity of the apoE codon 112 capture probes target (Fig. 1) . The aim was to increase the exposure of the apoE codon 112 SNP sense strand to its respective LNA capture probe thereby enhancing the absolute signals and the S/N ratios in the apoE assay. Both the LNA and DNA enhancers were included in the hybridization mixture and allowed simultaneous hybridization of the capture probe to the DNA target. As seen in Table 2 , the effect of the entries 7, 8 and 9 on the S/N ratios for both ssDNA and dsDNA targets was minimal. Although entry 10 had a lowering effect on the S/N ratio for the ssDNA targets, it signi®cantly increased the absolute values with dsDNA targets (data not shown) and improved the S/N ratio for the codon 112 TGC capture probe (Table 2) . A dose response curve for the effect of the LNA enhancers (entries 7±10) was performed to obtain optimal conditions for the apoE genotyping assay. Figure 2 shows a titration of the LNA enhancer entry 10 concentration ranging from 0 to 0.1 mM for the two capture probes challenged against the apoE codon 112 SNP. The optimal effect of the LNA enhancer was obtained at a ®nal concentration of 0.02 mM in the hybridization mixture. At the optimal LNA-enhancer concentration, the S/N ratios for the codons 112 TGC and CGC were 27.8 and 7.6, respectively. For comparison, we determined the S/N ratios using the corresponding DNA oligonucleotide. While a S/N ratio of 15.4 was observed for the codon TGC at the concentration of 0.1 mM, there was no apparent enhancing effect on the S/N ratio for the codon CGC (Table 3) . Therefore, all subsequent experiments were carried out using LNA-enhancer oligonucleotides. Further studies were made to ®ne-tune the enhancer properties of the LNA-enhancer entry 10. The LNA enhancer was designed in 22 different versions by moving the window of the probe one nucleotide at a time and/or by shortening the LNA enhancer. Entries 11±16 in Table 4 show a selection of the LNA enhancers. None of the tiled 11mer LNA enhancers (entries 11 and 12) improved the S/N ratios for either codon 112 CGC or codon 112 TGC capture probes. When the original LNA enhancer (entry 10) was shortened at either the 3¢ or 5¢ end (entries 13 and 14) by 1 nt, a signi®cant improvement of the S/N ratios and the absolute values for both capture probes was observed. Further shortening of the enhancer by 2 or 3 nt at the 3¢ end (entries 15 and 16) did not result in additional improvement. (Fig. 3) , represents the most powerful LNA enhancer for both the codon 112 and 158 found by this scanning procedure. The optimal ®nal concentration for this LNA enhancer (entry 13) was also found to be 0.02 mM in the hybridization mixture.
Finally, the apoE LNA genotyping assay was applied to a selected panel of patient samples previously genotyped for the apoE polymorphisms (24) (Fig. 4) . Puri®ed genomic DNA from the patients was used as template in the ampli®cation of the apoE PCR products. The apoE genotyping assay resulted in clear, unambiguous results for all patient samples, concurring with the genotypes obtained by DNA sequencing (Fig. 5) . 
DISCUSSION
We have established a new genotyping method for the detection of the human apoE codon 112 and 158 SNPs. The LNA capture probes for the apoE codon 158 demonstrated the usefulness of octamer LNA oligonucleotides in SNP genotyping. In contrast to DNA oligonucleotides, the use of LNA oligonucleotide capture probes results in an increased duplex melting temperature with a simultaneous increase in the DT m between the perfectly matched and mismatched targets (data not shown). These properties of LNA broaden the interval in which it is possible to ®nd optimal conditions for speci®c hybridization to a matched target compared with a single mismatched target (25) . Similar favorable hybridization properties could be obtained with LNA capture probes for the apoE codon 112 SNP when tested against ssDNA targets. In contrast, the codon 112 capture probes were not able to hybridize speci®cally to the corresponding dsDNA targets. The duplex melting temperatures for the codon 112 capture probes were comparable to those of the codon 158 capture probes, in line with the hybridization results obtained with ssDNA targets. This suggests that the target strands themselves do not form secondary structures thereby preventing hybridization to the capture probes. As discussed by Bernard et al. (6) , genotyping of dsDNA amplicons can be complicated; in particular this is true for GC-rich regions as is the case with the codon 112 in the apoE.
Previous NMR studies of LNA oligonucleotides hybridized to complementary DNA oligonucleotides have shown that conformationally restricted LNA oligonucleotides introduce a more ef®cient stacking of the nucleobases. In turn, this twists the B-type dsDNA helix structure into an A-type helix structure thereby enhancing hybridization ef®ciency (26) . Furthermore, short DNA oligonucleotides adjacent to each other have been reported to induce a several-fold increase in priming the complementary strand (27, 28) . Lane et al. (23) have shown that the strongest base-pair stacking interactions between neighboring DNA oligonucleotides occur when the oligonucleotides are situated`head-to-tail' separated by a nick only, and not by a single nucleotide gap. The change in the helix structure when a LNA/DNA hybrid is formed might favor the hybridization to the capture probes by LNA co-axial stacking interactions.
The present study using LNA enhancers implies that LNA oligonucleotides can be designed to enhance the speci®c recognition of the target in hybridization-based SNP assays together with LNA capture probes. In contrast, the corresponding DNA oligonucleotides were not found to be useful in the apoE genotyping assay. To further extend the use of LNAenhancer oligonucleotides in hybridization-based assays and to provide general LNA design rules requires additional experiments. Genotyping methods based on DNA target recognition require a high level of sensitivity and speci®city in order to discriminate effectively between target sequences differing by one nucleotide only. This has been achieved with the present apoE assay based on the LNA technology, thus demonstrating that LNA oligonucleotides are well suited for SNP detection. However, SNP detection of targets in GC-rich or structured regions may require an additional LNA-enhancer oligonucleotide, as shown here with the apoE codon 112 SNP. Conformational ®xation of the sugar moiety in the LNA nucleotide enables the design of short LNA capture probes capable of identifying DNA targets differing by a single nucleotide only. The present work demonstrates that the combined use of the LNA capture probes and enhancer oligonucleotides together with the AQ technology provides a simple, fast and sensitive assay for genotyping of the apoE alleles. The digital read-out of the microtiter plate makes the present apoE genotyping assay well suited for highthroughput screening of the apoE polymorphisms in clinical laboratories at a low cost. Hence, by combining these technologies it should be relatively straightforward to use the assay in high-throughput clinical screening programs or to miniaturize the assay onto a microarray platform.
